Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer Cover

.blurhash-client-img { display: none !important; }

Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer

Endocrine Regulations

Volume 51 (2017): Issue 3 (July 2017)

By: S Ozmen, O Timur, I Calik, K Altinkaynak, E Simsek, H Gozcu, A Arslan and A Carlioglu

Open Access

|Aug 2017

Metrics

DOI: https://doi.org/10.1515/enr-2017-0013 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 131 - 136

Published on: Aug 30, 2017

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

neutrophil-lymphocyte ratio,

platelet-lymphocyte ratio,

C-reactive protein,

differentiated thyroid cancer

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2017 S Ozmen, O Timur, I Calik, K Altinkaynak, E Simsek, H Gozcu, A Arslan, A Carlioglu, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 51 (2017): Issue 3 (July 2017)Next article